Used in pharmaceutical research as a potent and selective antagonist of the histamine H3 receptor, this compound shows potential for treating central nervous system disorders such as narcolepsy, attention deficit hyperactivity disorder (ADHD), and Alzheimer's disease. Its ability to modulate neurotransmitter release, particularly acetylcholine and dopamine, makes it a candidate for cognitive enhancement and wake-promoting therapies. Preclinical studies indicate good blood-brain barrier penetration and favorable pharmacokinetic properties, supporting its use in developing novel neurotherapeutics.